Abstract:Simple summary: Studies have shown that about 30% of kidney cancer patients will have metastasis, and lymph node metastasis (LNM) may be related to a poor prognosis. Our retrospective study aims to provide a reliable machine learning-based model to predict the occurrence of LNM in kidney cancer. We screened the pathological grade, liver metastasis, M staging, primary site, T staging, and tumor size from the training group (n=39016) formed by the SEER database and the validation group (n=771) formed by the medical center. Independent predictors of LNM in cancer patients. Using six different algorithms to build a prediction model, it is found that the prediction performance of the XGB model in the training group and the validation group is significantly better than any other machine learning model. The results show that prediction tools based on machine learning can accurately predict the probability of LNM in patients with kidney cancer and have satisfactory clinical application prospects. Background: Lymph node metastasis (LNM) is associated with the prognosis of patients with kidney cancer. This study aimed to provide reliable machine learning-based (ML-based) models to predict the probability of LNM in kidney cancer. Methods: Data on patients diagnosed with kidney cancer were extracted from the Surveillance, Epidemiology and Outcomes (SEER) database from 2010 to 2017, and variables were filtered by least absolute shrinkage and selection operator (LASSO), univariate and multivariate logistic regression analyses. Statistically significant risk factors were used to build predictive models. We used 10-fold cross-validation in the validation of the model. The area under the receiver operating characteristic curve (AUC) was used to assess the performance of the model. Correlation heat maps were used to investigate the correlation of features using permutation analysis to assess the importance of predictors. Probability density functions (PDFs) and clinical utility curves (CUCs) were used to determine clinical utility thresholds. Results: The training cohort of this study included 39,016 patients, and the validation cohort included 771 patients. In the two cohorts, 2544 (6.5%) and 66 (8.1%) patients had LNM, respectively. Pathological grade, liver metastasis, M stage, primary site, T stage, and tumor size were independent predictive factors of LNM. In both model validation, the XGB model significantly outperformed any of the machine learning models with an AUC value of 0.916.A web calculator (https://share.streamlit.io/liuwencai4/renal_lnm/main/renal_lnm.py) were built based on the XGB model. Based on the PDF and CUC, we suggested 54.6% as a threshold probability for guiding the diagnosis of LNM, which could distinguish about 89% of LNM patients. Conclusions: The predictive tool based on machine learning can precisely indicate the probability of LNM in kidney cancer patients and has a satisfying application prospect in clinical practice.

A machine learning model for predicting the lymph node metastasis of early gastric cancer not meeting the endoscopic curability criteria

A Risk-Scoring Model for Predicting Lymph Node Metastasis in Early Gastric Cancer Patients: a Retrospective Study and External Validation

A Clinical Model to Predict Distant Metastasis in Patients with Superficial Gastric Cancer with Negative Lymph Node Metastasis and a Survival Analysis for Patients with Metastasis

Application of Machine Learning Algorithms to Predict Lymph Node Metastasis in Early Gastric Cancer

A retrospective analysis based on multiple machine learning models to predict lymph node metastasis in early gastric cancer

Preoperative prediction for lymph node metastasis in early gastric cancer by interpretable machine learning models: A multicenter study

Predictive model for the preoperative assessment and prognostic modeling of lymph node metastasis in endometrial cancer

Predictive value of machine learning models for lymph node metastasis in gastric cancer: A two-center study

Development and Validation of Models to Predict Lymph Node Metastasis in Early Gastric Cancer Using Logistic Regression and Gradient Boosting Machine Methods

Machine learning models predict lymph node metastasis in patients with stage T1-T2 esophageal squamous cell carcinoma

Machine learning models for prediction of lymph node metastasis in patients with T1b gastric cancer

Risk factors and development of machine learning diagnostic models for lateral lymph node metastasis in rectal cancer: multicentre study

Application of Machine Learning in the Diagnosis of Early Gastric Cancer Using the Kyoto Classification Score and Clinical Features Collected from Medical Consultations

Interpretable deep learning model to predict lymph node metastasis in early gastric cancer using whole slide images

Utility of Machine Learning Models to Predict Lymph Node Metastasis of Japanese Localized Prostate Cancer

Novel machine‐learning model for predicting lymph node metastasis in resectable pancreatic ductal adenocarcinoma

Machine learning predicts lymph node metastasis of poorly differentiated-type intramucosal gastric cancer

Machine learning to predict distant metastasis and prognostic analysis of moderately differentiated gastric adenocarcinoma patients: a novel focus on lymph node indicators

Construction and Validation of a Risk-Scoring Model That Preoperatively Predicts Lymph Node Metastasis in Early Gastric Cancer Patients.

Development and validation of a machine learning model to predict the risk of lymph node metastasis in renal carcinoma

Machine learning-based gray-level co-occurrence matrix signature for predicting lymph node metastasis in undifferentiated-type early gastric cancer